Please login to the form below

Not currently logged in
Email:
Password:

Penn launches US operation

UK-based Penn Pharmaceutical Services has launched a company in North America, in the next phase of its growth in the region after a recent GBP 67m (USD 139.5m) management buyout.

UK-based Penn Pharmaceutical Services has launched a company in North America, in the next phase of its growth in the region after a recent GBP 67m (USD 139.5m) management buyout.

Penn, which provides integrated pharmaceutical outsourcing services, has set up Penn Pharmaceutical Services US in Philadelphia. The company has hired Paul Wituschek as director of business development to head up the new business arm.

Penn employs more than 200 people and operates from a base in Wales. It provides a variety of technical services to the pharmaceutical industry through three core divisions.

Wituschek has over 20 years' experience in executive level sales, marketing and management experience in private sector business. He has also worked in pharmaceutical, biotechnology, healthcare, insurance and publishing industries, managing teams globally throughout North America, the UK and the EU.

Most recently, Wituschek was global sales director for the Pharma Solutions Business Unit of US-based Wolters Kluwer Health, where he had profit and loss responsibility for the Global Business Intelligence portfolio and led his teams to record sales and revenue growth.

Penn Pharmaceutical's CEO, Peter George, said: "Development of our North American office is critical to maintain our planned growth rate of over 20 per cent and Paul has all of the assets required to drive the business forward and increase our presence there. As a member of the executive management team, Paul will ensure that future developments take account of the North American market needs."

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics